Colgate-Palmolive has just seen its price target updated, signaling that analysts are rethinking how they see the stock today ...

Colgate-Palmolive stock was up on the back of strong quarterly earnings.

JP Morgan analyst Andrea Teixeira maintained an Overweight rating and raised the price target from $88 to $93 on Jan. 16, 2026. This analyst has an accuracy rate of 60%. UBS analyst Peter Grom ...

TD Cowen analyst Robert Moskow lowered the firm’s price target on Colgate-Palmolive (CL) to $110 from $115 and keeps a Buy rating on the shares. The firm attributes the pullback in Colgate stock after ...

Colgate-Palmolive (CL) came out with quarterly earnings of $0.95 per share, beating the Zacks Consensus Estimate of $0.91 per ...

In this article, I will present an analysis of Colgate-Palmolive (CL), which is one of the leaders in the household products industry with headquarters in New York. Since the beginning of 2025, its ...

Consumer products company Colgate-Palmolive (NYSE:CL) in Q4 CY2025, with sales up 5.8% year on year to $5.23 billion. Its non ...

Palmolive (NYSE: CL) reported fourth quarter EPS of $0.95, $0.04 better than the analyst estimate of $0.91. Revenue for the quarter came in at $5.23B versu ...

Colgate-Palmolive (India) shares stayed under pressure after muted Q3FY26 results, as brokerages retained 'Sell' ratings citing weak volume growth, structural challenges in oral care, and limited ...

With consumer staples stocks out of favor, Colgate-Palmolive's share price slumped in 2025. The company has accelerated its product development pace. Colgate-Palmolive has met or exceeded its organic ...